We characterized the albumin‐binding and cancer‐targeting properties of ABP‐HBVC and further evaluated its immunogenicity through cytokine and antibody titer assays using live mice that were intravenously or intraperitoneally injected with ABP‐HBVC. Here, ALB is linked to cancer.